BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|September 6, 2019
- September 2019 Pain Management
- Volume 85
- Issue 9
Evolving Strategies in the Management of HIV: An Update for Pharmacists
New and emerging strategies in the management of HIV
Advertisement
Faculty
Eric K. Farmer, PharmD, BCPS, AAHIVP, HIV Clinical Pharmacist, Indiana University Health, LifeCare Clinic; Indianapolis, Indiana
Educational Objectives
At the completion of this activity, the participant will be able to:
- Explore the burden of HIV and evolving treatment strategies
- Identify current guideline recommendations and therapies, as well as emerging treatment options that may be used to optimize the management of patients with or at risk for HIV
- Examine strategies that pharmacists may employ to improve patient adherence, treatment satisfaction, and overall outcomes
Target audience: Pharmacists
Activity type: Application
Release date: September 16, 2019
Expiration date: September 16, 2020
Estimated time to complete activity: 2.5 hours
Fee: This lesson is offered for free at
Articles in this issue
about 7 years ago
Keep an Eye on Protein Kinase Inhibitorsabout 7 years ago
OTC Focus Case Studies: Painabout 7 years ago
What Are the Options for Treating Pain?about 7 years ago
Education, Law Enforcement, and Treatment Programs Are Keyabout 7 years ago
Dispensing Mistakes Can Happen to Pets, Tooabout 7 years ago
MRPs Are Both a Blessing and a Curseabout 7 years ago
Pharmacists Can Provide Optimal Migraine Treatmentsabout 7 years ago
Melrose Pharmacy Offers a Unique Feelabout 7 years ago
Topical Analgesics Provide Pain Reliefabout 7 years ago
Case Studies (September 2019)Advertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
2
What the 2025-2030 Dietary Guidelines Mean for Heart Health
3
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
4
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
5